Sign in to fuzzto save your conversations, follow your research and come back anytime.
Transpek Industry
SectorChemicals
The Quarter story
The two most recent quarterly results, compared side-by-side.
Transpek Industry stabilizes earnings after a tough FY26, driven by a sharp pivot to domestic markets and specialty chemicals despite rising input costs.
Finance costs drop from ₹2.5 Cr in Q1 FY26 to ₹1.5 Cr in Q1 FY27, lowering interest burden.
Material consumption costs jump from ₹62.2 Cr in Q4 FY26 to ₹87.2 Cr in Q1 FY27, squeezing production margins.
Domestic revenue share grows from 17.3% in Q1 FY26 to 32.7% in Q1 FY27, strengthening local market presence.
International revenue share drops from 83.9% in Q2 FY26 to 22.34% in Q1 FY27, reflecting a major geographic shift.
Specialty chemicals mix expands from 6.8% in Q3 FY26 to 22.5% in Q1 FY27, diversifying the product portfolio.
Polymers revenue mix contracts from 68.5% in Q3 FY26 to 48.7% in Q1 FY27, reducing core segment reliance.
European revenue share rebounds from 9.3% in Q2 FY26 to 16.9% in Q1 FY27, restoring regional demand.
Inventory changes reverse to -₹14.6 Cr in Q1 FY27 from ₹10.0 Cr in Q4 FY26, signaling aggressive destocking.
Employee expenses stabilize at ₹18.4 Cr in Q1 FY27 after fluctuating between ₹18.1 Cr and ₹19.2 Cr in FY26, keeping payroll predictable.
EBITDA margin recovers to 15.6% in Q1 FY27 from 14.4% in Q4 FY26, but remains below the 21.5% peak in Q1 FY26.
